Neonatal Care Transparency Act of 2026
- Bill Number
- H.R. 7912
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-03-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-05-15T20:39:32Z
AI-Generated Summary
Purpose
The Neonatal Care Transparency Act of 2026 (H.R. 7912) aims to increase transparency in neonatal care by requiring hospitals and obstetric providers (doctors or practitioners delivering babies) to disclose their policies on providing life-saving treatment to premature infants (babies born too early). It addresses variations in hospital practices, especially for extremely premature babies (e.g., before 22 weeks of pregnancy), to help parents make informed decisions.
Key Provisions
- Hospital Disclosures (Section 3(a)): Hospitals must publicly share their policy on life-saving care for premature infants, covering:
- Any minimum gestational age (weeks of pregnancy) for providing such care.
- Whether decisions are made case-by-case.
- Transfer process to the nearest facility with a neonatal intensive care unit (NICU, a specialized unit for newborns) if the hospital cannot provide care.
- Practitioner Disclosures (Section 3(b)): Obstetric providers must inform patients of the hospital's policy at the first prenatal visit.
- Enforcement via Medicare (Section 4): Hospitals participating in Medicare must comply and ensure their obstetric providers do too, starting January 1, 2026.
- Funding Penalties (Section 5): Non-compliant hospitals and obstetric providers lose federal funding under Medicaid (health coverage for low-income people) and CHIP (Children's Health Insurance Program), effective 180 days after enactment.
Significant Changes to Existing Law
- Amends Section 1866(a)(1) of the Social Security Act to add disclosure requirements as a condition for Medicare provider agreements.
- Amends Section 1903(i) of the Social Security Act to prohibit Medicaid payments to non-compliant hospitals and obstetric providers.
- Amends Section 2107(e)(1)(O) to extend the Medicaid prohibition to CHIP.
These tie compliance directly to federal healthcare funding, creating a new financial incentive for transparency.
Potential Impacts
- On Citizens: Pregnant individuals and parents of premature infants gain clear information upfront, enabling better choices about delivery locations and potentially improving infant outcomes by directing care to intervention-ready facilities.
- On Government Agencies: The Centers for Medicare & Medicaid Services (CMS) must oversee compliance, monitor disclosures, and enforce funding cuts, increasing administrative workload.
- On Healthcare Providers: Hospitals and obstetricians face mandates to update policies, post information publicly, and inform patients, with risk of losing significant federal revenue (Medicaid/CHIP funds a large share of births).
- No direct impact on international relations.
Main Stakeholders Affected
- Hospitals (especially those with NICUs, levels 3 and 4).
- Obstetric providers (doctors/practitioners with hospital admitting privileges).
- Pregnant patients at risk of premature birth.
- Parents of premature infants.
- Federal government (CMS, via Medicare, Medicaid, CHIP funding).
- Infants born prematurely (indirectly, through access to care).
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes enforceable disclosure rules linked to federal funding, potentially leading to lawsuits over compliance or funding denials; relies on existing provider agreement mechanisms in the Social Security Act.
- Constitutional: Supports informed consent by providing prenatal transparency, aligning with patient rights; no apparent conflicts with privacy or due process, as disclosures are policy-based, not individualized medical records.
- Political: Highlights debates on premature infant viability and care standards; could influence state-level policies or hospital practices amid discussions on abortion limits and neonatal ethics, without regulating abortion directly.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Recent Actions
- 2026-03-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-03-12: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2026-03-12: Introduced in House
- 2026-03-12: Introduced in House
Bill Versions
- Neonatal Care Transparency Act of 2026 — issued 2026-03-12 — PDF (6 pages)